Localization of lymphocyte apoptosis in murine lymphoid tissues after stimulation of natural killer T cells with alpha-galactosylceramide

被引:1
|
作者
Fujii, H
Seki, S
Nakatani, K
Ikeda, K
Ikemoto, M
Nakajima, Y
Arakawa, T
Kaneda, K
机构
[1] Osaka City Univ, Sch Med, Dept Anat, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Sch Med, Dept Internal Med, Osaka 545, Japan
关键词
D O I
10.1679/aohc.66.397
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alpha-galactosylceramide (alpha-GalCer) has been reported to induce activation-induced cell death (AICD) in natural killer T (NKT) cells. We undertook this study to demonstrate the distribution of AICD of NKT cells in the lymphoid tissues and differences in frequency between the central and peripheral lymphoid tissues, histologically and quantitatively analyzing the apoptotic figure in the murine spleen, lymph node, and thymus after alpha-GalCer treatment. Lymphocyte apoptosis was identified as a cluster of nuclei with chromatin condensation in hematoxylin-eosin-stained sections, and was confirmed by TUNEL staining, double staining for TUNEL and CD4, and electron microscopy. In the spleen, it appeared at 12 It after alpha-GalCer administration, increased in number, reaching a peak at 24 h, and then failing to a normal level at 72 h. It was preferentially found in the white pulp, especially in the periarterial lymphoid sheath, but was sparse in the red pulp. Alpha-GalCer-induced lymphocyte apoptosis was seen in tumor-necrosis factor (TNF)-dericient mice as well, but was not in lpr/lpr (Fas-deficient) or gld/gld (Fas ligand-deficient) mice. As for the tissue distribution, lymphocyte apoptosis was frequently seen in the paracortex of the lymph node, whereas it was rare in the thymus. These data indicate that alpha-GalCer-induced AICD of NKT cells takes place in the T-cell area of peripheral lymphoid tissues (i.e., the spleen and lymph node) through the Fas/Fas ligand, but not the TNF pathway.
引用
收藏
页码:397 / 406
页数:10
相关论文
共 47 条
  • [1] ACTIVATION OF NATURAL KILLER T CELLS BY ALPHA-GALACTOSYLCERAMIDE AFFECTS IRON METABOLISM
    Huang, Hua
    Fragoso, Gabriela
    Santos, Manuela
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E127 - E127
  • [2] Activation of natural killer T (NKT) cells by alpha-galactosylceramide mediates clearance of E.coli in murine urinary tract infection
    Minagawa, S
    Ohyama, C
    Hatakeyama, S
    Sato, K
    Satoh, S
    Habuchi, T
    JOURNAL OF UROLOGY, 2004, 171 (04): : 22 - 23
  • [3] Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice
    Obata, Y.
    Ishimori, N.
    Saito, A.
    Kinugawa, S.
    Nakano, I.
    Kakutani, N.
    Yamanashi, K.
    Anzai, T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 925 - 925
  • [4] Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice
    Obata, Yoshikuni
    Ishimori, Naoki
    Saito, Akimichi
    Kinugawa, Shintaro
    Yokota, Takashi
    Takada, Shingo
    Nakano, Ippei
    Kakutani, Naoya
    Yamanashi, Katsuma
    Anzai, Toshihisa
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (19) : 2358 - 2361
  • [5] Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide
    Croudace, Joanne E.
    Curbishley, Stuart M.
    Mura, Manuela
    Willcox, Carrie R.
    Illarionov, Petr A.
    Besra, Gurdyal S.
    Adams, David H.
    Lammas, David A.
    BMC IMMUNOLOGY, 2008, 9 (1)
  • [6] Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide
    Joanne E Croudace
    Stuart M Curbishley
    Manuela Mura
    Carrie R Willcox
    Petr A Illarionov
    Gurdyal S Besra
    David H Adams
    David A Lammas
    BMC Immunology, 9
  • [7] In-vivo stimulation of macaque natural killer T cells with -galactosylceramide
    Fernandez, C. S.
    Jegaskanda, S.
    Godfrey, D. I.
    Kent, S. J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 173 (03): : 480 - 492
  • [8] Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15
    Hsu, Chien-Ya
    Chueh, Yu-Shan
    Kuo, Ming-Ling
    Lee, Pei-Tzu
    Hsiao, Hsiu-Shan
    Huang, Jing-Long
    Lin, Syh-Jae
    PLOS ONE, 2021, 16 (12):
  • [9] Reversal of established autoimmune diabetes by H60-loaded immature dendritic cells plus the natural killer T cells ligand alpha-Galactosylceramide
    Yang, Wen
    Song, Xiaoping
    Chung, Kyungmee
    Wilson, Brian
    FASEB JOURNAL, 2008, 22
  • [10] Treatment of Donors with Liposomal Alpha-Galactosylceramide Results in the In Vivo Expansion of Invariant Natural Killer T Cells and Reduced Incidence of Acute Graft Versus Host Disease
    Hirai, Toshihito
    Simonetta, Federico
    Baker, Jeanette
    Maas-Bauer, Kristina
    Turkoz, Musutafa
    Alvarez, Maite
    Mavers, Melissa
    Negrin, Robert S.
    BLOOD, 2017, 130